Children and young people aged 12 to 17 years, who have recently tested positive for coronavirus, should wait 12 weeks after the date they were tested to get the vaccine. However, if you're aged 5 to 17 and at increased risk, you can have your coronavirus vaccine from 4 weeks after coronavirus infection.
All children and young people aged 12 to 17 will be offered two doses of the COVID-19 vaccine. The second dose will be offered from 12 weeks after the first dose. For more information about requesting your vaccine, please click here (opens in new tab).
Some children and young people aged 12 to 17 years are also eligible for a booster dose.
The Joint Committee on Vaccination and Immunisation (JCVI) recommends that the booster dose of the coronavirus vaccine is offered to:
For COVID-19 vaccine information leaflets for children and young people please click here (opens in new tab).
We are preparing to invite at-risk children aged 5-11 following recommendations made by the Joint Committee for Vaccination and Immunisation (JCVI) (opens in new tab) and approval of a child-specific Pfizer-BioNtech vaccine by the Medicines and Healthcare products Regulatory Agency (MHRA) (opens in new tab).
The JCVI has recommended that children aged 5 to 11 who are in an “at-risk” group or are the household contact of someone who is immunosuppressed should be offered two doses of the Pfizer-BioNTech vaccine, eight weeks apart. The minimum interval between any vaccine dose and COVID-19 infection should be four weeks.
Chronic respiratory disease
Including those with poorly controlled asthma that requires continuous or repeated use of systemic steroids or with previous exacerbations requiring hospital admission, cystic fibrosis, ciliary dyskinesias and bronchopulmonary dysplasia
Chronic heart conditions
Haemodynamically significant congenital and acquired heart disease, or less severe heart disease with other co-morbidity. This includes:
Chronic conditions of the kidney, liver or digestive system
Including those associated with congenital malformations of the organs,
metabolic disorders and neoplasms, and conditions such as severe gastro oesophageal reflux that may predispose to respiratory infection
Chronic neurological disease
This includes those with
Including diabetes mellitus, Addison’s and hypopituitary syndrome
Immunosuppression due to disease or treatment, including:
Asplenia or dysfunction of the spleen
Including hereditary spherocytosis, homozygous sickle cell disease and thalassemia major
Serious genetic abnormalities that affect a number of systems
Including mitochondrial disease and chromosomal abnormalities
All stages (first, second and third trimesters)